期刊文献+

126株嗜麦芽窄食单胞菌的临床分布特征及耐药性分析 被引量:4

Analysis on clinical distribution characteristics and drug resistance of 126 strains of Stenotrophomonas maltophilia
下载PDF
导出
摘要 目的分析医院感染常见非发酵菌嗜麦芽窄食单胞菌的分布特征及耐药情况。方法常规方法进行细菌培养鉴定,琼脂纸片扩散(K-B)法检测嗜麦芽窄食单胞菌对10种抗菌药物的药敏结果。结果 126株嗜麦芽窄食单胞菌分布各异,对10种抗菌药物均存在耐药,耐药率为7.0%~75.0%。结论嗜麦芽窄食单胞菌已成为医院感染的重要致病菌,对多种抗菌药物存在高耐药率,而且耐药率在逐年上升,指导临床合理用药,药敏检测工作具有非常重要的意义。 Objective To analyze the distribution characteristics and drug resistance of the common nonfermenters Stenotrophomonas maltophilia in nosocomial infection.Methods To perform the identification of bacterial culture by conventional methods,the drug sensitivity of Stenotrophomonas maltophilia to 10 kinds of antibacterial drugs by K-B.Results 126 strains of Stenotrophomonas maltophilia were distributed differently,and had resistance to all the 10 kinds of antibacterial drugs,the drug-resistant rate was 7.0%-75.0%.Conclusion Stenotrophomonas maltophilia has become important pathogen of nosocomial infection,with high drug-resistant rate to multiple antibiotics,which increases year by year,so that the drug sensitivity testing work is of great significance to guide clinical rational administration of drugs.
出处 《检验医学与临床》 CAS 2010年第11期1044-1044,1047,共2页 Laboratory Medicine and Clinic
关键词 嗜麦芽窄食单胞菌 抗菌药物 耐药性 stenotrophomonas maltophilia antibacterial drugs resistance
  • 相关文献

参考文献3

二级参考文献39

  • 1王辉,刘颖梅,陈民钧,孙宏莉,谢秀丽,徐英春.鲍曼不动杆菌对碳青霉烯类耐药机制的研究[J].中国医学科学院学报,2003,25(5):567-572. 被引量:44
  • 2周月清,陆开来,糜祖煌.鲍曼不动杆菌TEM基因及氨基糖苷类修饰酶基因初步研究[J].中华检验医学杂志,2005,28(2):200-202. 被引量:64
  • 3Sengupta S, Kumar P, Ciraj AM, et al. Acinetobacter baumannii-An emerging nosocomial pathogen in the bums unit Manipal, india. Bums,2001, 27(2):140-144.
  • 4Vahaboglu H, Ozturk R, Aygun G , et al. Widespread detection of PER-1-type extended-spectrum b-lactarnases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide muhicenter stndy. Antimicrob Agents Chemother 1997 ; 41 (10) : 2265-2269.
  • 5Poirel L, Menuteau O, Agoli N, et al. Outbreak of extended-spectrum b-lactmase VEB-1 producing isolates of Acinetobacter baumannii in a French hospital. J Clin Microbiol 2003 ; 41 ( 8 ) : 3542-3547.
  • 6Danes C, Navia MM, Ruiz J, etal. Distribution of beta-lactamases in Acinetobacter baumannii clinical isolates and the effect of Svn 2190 ( Am-pC inhibitor) on the MICs of different beta-lactam antibiotics. J Antimicrob Chemother., 2002 Aug; 50(2) : 261-264.
  • 7Limansky AS, Mussi Ma, Viale AM, et al. Loss of 29kD outer membrane protein in Acinetobacter baumannii is associated with imipenem resistance. J Clin Microb. 2002, 40(12) : 4776-4778.
  • 8Costa SF. Outer membrane proteins pattern and detection of β-Lactamases in clinical isolates of imipenem-resistant Acinetobacter baumannii from Brazil. Int J Antimicrob Agents, 2000, 13 (3) : 175.
  • 9Fernandez-Cuenca F, Martinez-Martinez L, Conejo MC, et al. Relationship between beta-lactamases production, outer membrane protein and penicillin-binding protein profile on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. Journal of Antimicrobial Chemotherapy, 2003,51 ( 3 ) : 565-574.
  • 10Donald HM, Scaife W, Amyes SG, et al. Sequence analysis of ARI-1, a novel OXAβ-lactamase, responsible for imipenem resistance in Acinetobacter baumanii. Antimicrob Agents Chemother, 2000,44 ( 1 ) : 196-199.

共引文献307

同被引文献53

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部